NEW YORK (GenomeWeb) – Becton Dickinson said today that its fiscal third quarter revenues grew 45 percent year over year largely on its recent acquisition of medical technology firm CareFusion.

For the three months ended June 30, BD recorded revenues of $3.12 billion compared to $2.16 billion in fiscal Q3 2014, and just shy of the consensus analysts' estimate of $3.13 billion. On a comparable, currency-neutral basis, adjusted revenues grew just over 2 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.